Carl Torbjörn Bäckström
Director/Board Member chez DIAMYD MEDICAL AB
Fortune : 980 $ au 31/03/2024
Profil
Carl Torbjörn Bäckström is the founder of Umecrine AB (founded in 2000), Asarina Pharma AB (founded in 2006), and Umecrine Cognition AB (founded in 2006).
He held the title of Chief Executive Officer & Director at Umecrine AB, Chief Science Officer at Asarina Pharma AB, and Chief Science Officer & Director at Umecrine Cognition AB.
Currently, he is an Independent Director at Diamyd Medical AB (since 2017), Senior Professor at Umea Universitet, Professor at Obstetrics & Gynecology, Inc., and Principal at Umeå Neurosteroid Research.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/08/2023 | 1 000 ( 0,00% ) | 980 $ | 31/03/2024 |
Postes actifs de Carl Torbjörn Bäckström
| Sociétés | Poste | Début |
|---|---|---|
| DIAMYD MEDICAL AB | Director/Board Member | 01/04/2017 |
Umecrine AB
 Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Founder | 02/06/2010 |
Obstetrics & Gynecology, Inc.
 Obstetrics & Gynecology, Inc. Medical/Nursing ServicesHealth Services Obstetrics & Gynecology, Inc. engages in providing obstetrics and gynecology (ObGyn) and women's health services. The company is headquartered in St. Louis, MO. | Corporate Officer/Principal | 02/06/2010 |
| Umea Universitet | Corporate Officer/Principal | 02/06/2010 |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Founder | 01/01/2006 |
| Umeå Neurosteroid Research | Corporate Officer/Principal | - |
Anciens postes connus de Carl Torbjörn Bäckström
| Sociétés | Poste | Fin |
|---|---|---|
| ASARINA PHARMA AB | Founder | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASARINA PHARMA AB | Health Technology |
| DIAMYD MEDICAL AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
Umecrine AB
Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Health Technology |
Obstetrics & Gynecology, Inc.
Obstetrics & Gynecology, Inc. Medical/Nursing ServicesHealth Services Obstetrics & Gynecology, Inc. engages in providing obstetrics and gynecology (ObGyn) and women's health services. The company is headquartered in St. Louis, MO. | Health Services |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Health Technology |
| Umeå Neurosteroid Research |
